Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma

Published:2023-08 Issue:8 Volume:26 Page:107369
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Liu Chuanxu,Ding Xinyu,Li Gaoyang,Zhang Youping,Shao Yubao,Liu Linyi,Zhang Wenhao,Ma Yujie,Guan Wenbin,Wang Lifeng,Xu Zhongli,Chang YungTing,Zhang Yongqiang,Jiang Biao,Yin Qianqian,Tao Rong

Funder

Shanghai Municipal Health Commission

National Natural Science Foundation of China

Shanghai Municipal Education Commission

Shanghai Municipality Science and Technology Commission

Shanghai Hospital Development Center

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference50 articles.

1. Epstein-Barr virus-positive natural killer/t-cell lymphoma;Cai;Front. Oncol.,2019

2. The diagnosis and management of NK/T-cell lymphomas;Tse;J. Hematol. Oncol.,2017

3. Extranodal NK/T cell lymphoma;Jeong;Blood Res.,2020

4. DDGP versus SMILE in newly diagnosed advanced natural killer/t-cell lymphoma: a randomized controlled, multicenter, open-label study in China;Li;Clin. Cancer Res.,2016

5. Induction treatment with SMILE and consolidation with autologous stem cell transplantation for newly diagnosed stage IV extranodal natural killer/T-cell lymphoma patients;Kim;Ann. Hematol.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP